Overview
Junryo Rii practices practicing medicine in Chiba, Japan.
Their clinical expertise encompasses Prostate Cancer, Cystinuria, Bone Tumor, Lung Metastases, and Prostatectomy.
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Junryo Rii
Is Junryo Rii a top-rated expert for Prostate Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Junryo Rii is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Junryo Rii participate in research or clinical trials?
Yes. Junryo Rii has published 14 articles and abstracts on conditions like Prostate Cancer. You can view a list of Junryo Rii's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Bone TumorRii isExperienced. Learn about Bone Tumor.
- CystinuriaRii isExperienced. Learn about Cystinuria.
- Lung MetastasesRii isExperienced. Learn about Lung Metastases.
- Prostate CancerRii isExperienced. Learn about Prostate Cancer.
- ProstatectomyRii isExperienced. Learn about Prostatectomy.